Haemonetics Corporation is a global healthcare company. The Company is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Companyâs technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Companyâs Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Companyâs Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
äŒæ¥ã³ãŒãHAE
äŒç€ŸåHaemonetics Corp
äžå Žæ¥Oct 17, 1979
æé«çµå¶è²¬ä»»è
ãCEOãSimon (Christopher A)
åŸæ¥å¡æ°3023
蚌åžçš®é¡Ordinary Share
æ±ºç®ææ«Oct 17
æ¬ç€Ÿæåšå°125 Summer Street
éœåžBOSTON
蚌åžååŒæNASDAQ OMX NASDAQ Basic NYSE
åœUnited States of America
éµäŸ¿çªå·02110
é»è©±çªå·17818487100
ãŠã§ããµã€ãhttps://www.haemonetics.com
äŒæ¥ã³ãŒãHAE
äžå Žæ¥Oct 17, 1979
æé«çµå¶è²¬ä»»è
ãCEOãSimon (Christopher A)
éå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã

ããŒã¿ãªã